Company: UHS
Filing Date: 2025-04-03
Form Type: DEF 14A
Source: 0000950170-25-049925
Chunk: 79

Company: UNIVERSAL HEALTH SERVICES INC
Filing Date: 2025-04-03
Form: DEF 14A
Chunk 79
---
.42 per share. The full grant date fair values of these awards were included in the Summary Compensation Table in the year of original grant.

Represents the intrinsic value of the accelerated performance based restricted stock units and time based restricted stock units based upon the closing price per share of the Class B Common Stock on the NYSE on December 31, 2024 of $179.42 per share. The full grant date fair values of these awards were included in the Summary Compensation Table in the year of original grant.

Other Executive Officers

In addition, in the event of an involuntary termination of their respective employment by the Company without cause, Messrs. Peterson and Sim are each entitled to receive salary continuation for 12 months. Messrs. Peterson and Sim are also entitled to reimbursement of a portion of their COBRA premium for 12 months. Assuming such an involuntary termination of their respective employment had occurred as of December 31, 2024, Messrs. Peterson and Sim would be entitled to receive aggregate cash severance payments of $759,283 and $845,816, respectively, and Messrs. Peterson and Sim would have been entitled to the reimbursement of a portion of their COBRA premium aggregating to $22,102 and $22,756, respectively.

| 45                                                   |
| Universal Health Services, Inc. 2025 Proxy Statement |

| Potential Payments Upon Termination or Change-in-Control |

Potential Payments upon a Change of Control

Pursuant to our 2020 Omnibus Stock and Incentive Plan, (as of December 31, 2024, all unvested awards of our named executive officers were granted under this plan), all of our employees receive full acceleration of the vesting of any unvested award in the event that such awards are not assumed or substituted by the surviving or acquiring company following a change of control of the Company.

The intrinsic value of our named executive officers’ stock options for which vesting would have accelerated assuming a change in control of the Company in which equity awards are not assumed or substituted had occurred as of December 31, 2024, is as follows: Marc D. Miller: $9,583,118; Alan B. Miller: $6,086,414; Steve G. Filton: $2,569,578; Matthew J. Peterson: $2,137,321 and Edward H. Sim: $1,266,375.

Additionally, the intrinsic value of our named executive officers’ performance based and time based restricted stock